Outcomes of 19 unplanned pregnancies in women participating in phase 2 or 3 eliglustat clinical trials and 18 pregnancies in the partners of men who participated in these trials

被引:2
|
作者
Balwani, Manisha [1 ]
Lukina, Elena [2 ]
Belmatoug, Nadia [3 ]
Watman, Nora [4 ]
Hughes, Derralynn [5 ]
Gaemers, Sebastiaan J. M. [6 ]
Kim, Yestle [6 ]
Foster, Mererdith [6 ]
Peterschmitt, M. Judith [6 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Natl Res Ctr Hematol, Moscow, Russia
[3] Univ Hosp Paris Nord Val de Seine, Paris, France
[4] Hosp Ramos Mejia, Buenos Aires, DF, Argentina
[5] UCL, Royal Free London NHS Fdn Trust, London, England
[6] Sanofi Genzyme, Cambridge, MA USA
关键词
D O I
10.1016/j.ymgme.2018.12.047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
31
引用
收藏
页码:S27 / S28
页数:2
相关论文
共 32 条
  • [1] Biologic sex is not the only difference between men and women: data from the Doravirine phase 2/3 clinical trials
    Walmsley, S.
    Squires, K.
    Martin, E.
    Xu, Z. J.
    Hwang, C.
    Sklar, P.
    Sordet, F.
    HIV MEDICINE, 2019, 20 : 92 - 92
  • [2] Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine
    Barthell, Elisabeth
    Woelber, Linn
    Hellner, Karin
    Camerer, Birka
    Gieseking, Friederike
    Hauschild, Maik
    Mylonas, Ioannis
    Friese, Klaus
    Sings, Heather L.
    Railkar, Radha
    Gause, Christine
    Barr, Eliav
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 279 (06) : 803 - 807
  • [3] Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine
    Elisabeth Barthell
    Linn Woelber
    Karin Hellner
    Birka Camerer
    Friederike Gieseking
    Maik Hauschild
    Ioannis Mylonas
    Klaus Friese
    Heather L. Sings
    Radha Railkar
    Christine Gause
    Eliav Barr
    Archives of Gynecology and Obstetrics, 2009, 279 : 803 - 807
  • [4] IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES WITH REVEFENACIN FOR NEBULIZATION IN WOMEN VS MEN WITH MODERATE TO VERY SEVERE COPD: SUBGROUP ANALYSES FROM PHASE 3 CLINICAL TRIALS
    Ferguson, Gary
    Feldman, Gregory
    Pudi, Krishna
    Lombardi, David
    Ohar, Jill
    Schneider, Roslyn
    CHEST, 2021, 160 (04) : 1777A - 1779A
  • [5] Microbiological Outcomes of 2 Multicenter Phase 3 Clinical Trials of Ceftaroline in Community-acquired Bacterial Pneumonia
    Critchley, I.
    Friedland, D.
    Eckburg, P.
    Jandourek, A.
    Han, S. -H.
    Thye, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [6] Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials
    Tambiah, Jeyanesh
    Kennedy, Sarah
    Swearingen, Christopher
    Mcalindon, Timothy
    Yazici, Yusuf
    RHEUMATOLOGY, 2024,
  • [7] Demographic and behavioral contextual risk groups among men who have sex with men participating in a phase 3 HIV vaccine efficacy trial - Implications for HIV prevention and behavioral/biomedical intervention trials
    Bartholow, Bradford N.
    Goli, Vamshidar
    Ackers, Marta
    McLellan, Eleanor
    Gurwith, Marc
    Durham, Marcus
    Greenberg, Alan E.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (05) : 594 - 602
  • [8] Characteristics of a Chronic Cough Population Participating in Two Large Phase III Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist
    Dicpinigaitis, P.
    McGarvey, L.
    Morice, A. H.
    Smith, J.
    Birring, S. S.
    Pavord, I. D.
    Iskold, B.
    Tzontcheva, A.
    Li, Q.
    La Rosa, C.
    Muccino, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials
    Szajewska, Hania
    Horvath, Andrea
    Koletzko, Berthold
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06): : 1337 - 1344
  • [10] Identification and Clinical Characterization of CNS Relapse in DLBCL Patients across 19 Prospective Phase 2 and 3 Trials - a GLA/ DSHNHL and LYSA Collaboration
    Frontzek, Fabian
    Renaud, Loic
    Duehrsen, Ulrich
    Poeschel, Viola
    Bernard, Sophie
    Chartier, Loic
    Ketterer, Nicolas
    Recher, Christian
    Fitoussi, Olivier
    Held, Gerhard
    Casasnovas, Rene-Olivier
    Haioun, Corinne
    Mounier, Nicolas
    Tilly, Herve
    Morschhauser, Franck
    Le Gouill, Steven
    Karsten, Imke E.
    Duns, Gerben
    Steidl, Christian
    Scott, David W.
    Klapper, Wolfram
    Rosenwald, Andreas
    Ott, German
    Molina, Thierry Jo
    Lenz, Georg
    Ziepert, Marita
    Altmann, Bettina
    Thieblemont, Catherine
    Schmitz, Norbert
    BLOOD, 2023, 142